Patent 11642417 was granted and assigned to Bonum Therapeutics, Inc. on May, 2023 by the United States Patent and Trademark Office.
Provided herein are protein complexes comprising a sensor domain and a therapeutic domain linked by a linker, and methods of use thereof. In aspects of the present disclosure, activity of the therapeutic domain comprises a dependence on sensor domain binding to target markers.